Literature DB >> 2275952

Further analysis of the control of voluntary saccadic eye movements in schizophrenic patients.

J Fukushima1, K Fukushima, N Morita, I Yamashita.   

Abstract

Many schizophrenic patients reveal abnormalities in the antisaccade task. To better understand the nature of these abnormalities, in the present study we have assigned to schizophrenics the no-saccade task (subjects were required to remain fixated without being disturbed by a reflexive saccade) and memory-saccade task (subjects were required to look at a remembered target) in addition to the antisaccade and saccade tasks used previously. Many schizophrenics revealed higher error rates in the no-saccade task, and latencies of saccades to a memorized target were significantly longer than controls in the memory-saccade task. Peak velocities of saccades of large amplitudes in the memory-saccade and antisaccade tasks (but not in the saccade task) were significantly slower and durations of such saccades were longer than normal controls despite the similarity between the distributions of amplitudes of such saccades between the patients and controls. These results suggest that many schizophrenics have difficulty suppressing reflexive saccades and initiating and executing appropriate volitional saccades when the goal for the movements is known but not visible.

Entities:  

Mesh:

Year:  1990        PMID: 2275952     DOI: 10.1016/0006-3223(90)90060-f

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  21 in total

1.  Suppression of reflexive saccades in younger and older adults: age comparisons on an antisaccade task.

Authors:  K M Butler; R T Zacks; J M Henderson
Journal:  Mem Cognit       Date:  1999-07

2.  The antisaccade task and neuropsychological tests of prefrontal cortical integrity in schizophrenia: empirical findings and interpretative considerations.

Authors:  Deborah L Levy; Nancy R Mendell; Philip S Holzman
Journal:  World Psychiatry       Date:  2004-02       Impact factor: 49.548

3.  Active eye fixation performance in 940 young men: effects of IQ, schizotypy, anxiety and depression.

Authors:  N Smyrnis; E Kattoulas; I Evdokimidis; N C Stefanis; D Avramopoulos; G Pantes; C Theleritis; C N Stefanis
Journal:  Exp Brain Res       Date:  2003-12-19       Impact factor: 1.972

Review 4.  Transcranial magnetic stimulation: studying motor neurophysiology of psychiatric disorders.

Authors:  Fumiko Maeda; Alvaro Pascual-Leone
Journal:  Psychopharmacology (Berl)       Date:  2003-06-26       Impact factor: 4.530

5.  The relationship of saccadic peak velocity to latency: evidence for a new prosaccadic abnormality in schizophrenia.

Authors:  Rajeev S Ramchandran; Dara S Manoach; Mariya V Cherkasova; Kristen A Lindgren; Donald C Goff; Jason J S Barton
Journal:  Exp Brain Res       Date:  2004-07-29       Impact factor: 1.972

6.  Hypometric primary saccades of schizophrenics in a delayed-response task.

Authors:  S Everling; P Krappmann; S Preuss; A Brand; H Flohr
Journal:  Exp Brain Res       Date:  1996-09       Impact factor: 1.972

7.  Improved antisaccade performance with risperidone in schizophrenia.

Authors:  J G Burke; M A Reveley
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-04       Impact factor: 10.154

8.  A novel computational model to probe visual search deficits during motor performance.

Authors:  Tarkeshwar Singh; Julius Fridriksson; Christopher M Perry; Sarah C Tryon; Angela Ross; Stacy Fritz; Troy M Herter
Journal:  J Neurophysiol       Date:  2016-10-12       Impact factor: 2.714

9.  Smooth-pursuit eye movement dysfunction in schizophrenia: the role of attention and general psychomotor dysfunctions.

Authors:  R Schlenker; R Cohen; P Berg; W Hubman; F Mohr; H Watzl; P Werther
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

Review 10.  The tell-tale tasks: a review of saccadic research in psychiatric patient populations.

Authors:  Diane C Gooding; Michele A Basso
Journal:  Brain Cogn       Date:  2008-10-23       Impact factor: 2.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.